★ ★ ★ ★ ★   Trusted by patients across the UK 9 in 10 patients qualify Specialist this week, not next year

CONDITION OVERVIEW

Medical cannabis
for epilepsy.

Treatment-resistant epilepsy, including paediatric cases.

600,000

people in the UK live with epilepsy.

Why patients turn to medical cannabis.

Medical cannabis (specifically CBD-rich formulations) was the first cannabis-based treatment licensed by the NHS, for severe paediatric epilepsy. For the third of patients whose seizures don't respond to standard anti-epileptic drugs, cannabinoid therapy has changed lives.

How medical cannabis helps

Three areas where regulated cannabis can make a measurable difference for epilepsy patients.

Treatment-resistant epilepsy

For patients where two or more anti-epileptic drugs have failed.

Paediatric epilepsy syndromes

Including Dravet and Lennox-Gastaut, where CBD has the strongest evidence base.

Reduction in seizure frequency

Studies show median seizure reduction of 30-40% in suitable cases.

Our daughter went from 60 seizures a week to under 5. She's back at school and back to herself.

Sarah Mother of a patient with Dravet syndrome

HOW IT WORKS

Three steps to start treatment.

0%

of patients can access medical cannabis through Omni Health Partners.

  1. 01

    Take the eligibility quiz

    4 questions, 2 minutes. Free, no commitment.

  2. 02

    Book your specialist consultation

    30-minute video call with a GMC-registered consultant. £99 — fully refunded if you're not eligible.

  3. 03

    Receive your prescription & kit

    Premium products plus your custom vaporiser, delivered in 5 working days.

Other conditions we treat

Find out if you're eligible.

Two minutes. No commitment. £99 fee fully refunded if you don't qualify.